Suchergebnisse - (Subject:"Siltuximab")

PubPharm (47)

11

Pharmacological treatment of COVID-19 : Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)

enthalten in: Medicina intensiva | 2021

von Díaz, E. | Amézaga Menéndez, R. | Vidal Cortés, P. | +6

12

Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome

enthalten in: International journal of medical sciences | 2021

von Du, P. | Geng, J. | Wang, F. | +3

13

Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease

enthalten in: Expert opinion on investigational drugs | 2020

von Zhou, Z. | Price, C.

14

Role of monoclonal antibody drugs in the treatment of COVID-19

enthalten in: World journal of clinical cases | 2020

von Ucciferri, C. | Vecchiet, J. | Falasca, K.

15

Involvement of interleukin 6 in SARS-CoV-2 infection : siltuximab as a therapeutic option against COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2020

von Palanques-Pastor, T. | López-Briz, E. | Poveda Andrés, J.

16

Effects of IL-6 Signaling Pathway Inhibition on Weight and BMI : A Systematic Review and Meta-Analysis

enthalten in: International journal of molecular sciences | 2020

von Patsalos, O. | Dalton, B. | Himmerich, H.

17

Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19 : Rationale, Clinical Evidence and Risks

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2020

von Crisafulli, S. | Isgrò, V. | La Corte, L. | +2

18

Cytokine storm intervention in the early stages of COVID-19 pneumonia

enthalten in: Cytokine & growth factor reviews | 2020

von Sun, X. | Wang, T. | Cai, D. | +9

CommentIn: Cytokine Growth Factor Rev. 2021 Apr;58:30-31. - PMID 32873506

19

Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition

enthalten in: Infectious disease clinics of North America | 2020

von Liu, A.

20

Outlook of IL-6 signaling blockade for COVID-19 pneumonia

enthalten in: Inflammation and regeneration | 2020

von Hashizume, M.